AMBIENT DOSE EQUIVALENT RECEIVED AT 15 MV LINAC ENVIRONMENTS DUE TO PHOTONEUTRONS CONTAMINATION
暂无分享,去创建一个
[1] K. Theodorou,et al. Thick-foils activation technique for neutron spectrum unfolding with the MINUIT routine-Comparison with GEANT4 simulations , 2018 .
[2] M. Axiotis,et al. SPECTRW: A software package for nuclear and atomic spectroscopy , 2016 .
[3] H. Yücel,et al. Measurement of Photo-Neutron Dose from an 18-MV Medical Linac Using a Foil Activation Method in View of Radiation Protection of Patients , 2016 .
[4] S. Stoulos,et al. Geant4 simulations on medical Linac operation at 18 MV: Experimental validation based on activation foils , 2016 .
[5] A. Konefał,et al. Measurements of neutron radiation and induced radioactivity for the new medical linear accelerator, the Varian TrueBeam , 2016 .
[6] S. Stoulos,et al. Analysis of improved neutron activation technique using thick foils for application on medical LINAC environment , 2016 .
[7] M. Hult,et al. Validation of a method for neutron dosimetry and spectrometry using neutron activation of metal discs. , 2010, Radiation protection dosimetry.
[8] D. Followill,et al. Secondary neutron spectra from modern Varian, Siemens, and Elekta linacs with multileaf collimators. , 2009, Medical physics.
[9] N. M. Spyrou,et al. Monte Carlo study of photoneutron production in the Varian Clinac 2100C linac , 2008 .
[10] J. Castelo,et al. Neutron measurements in a Varian 2,100C LINAC facility using a Bonner sphere system based on passive gold activation detectors. , 2007, Radiation protection dosimetry.
[11] B. Koo,et al. Evaluation of the photoneutron field produced in a medical linear accelerator. , 2007, Radiation protection dosimetry.
[12] Gary D Fullerton,et al. Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies. , 2006, Medical physics.
[13] N. Hertel,et al. Effective quality factors for neutrons based on the revised ICRP/ICRU recommendations. , 2005, Radiation protection dosimetry.
[14] G. Fullerton,et al. Investigation of secondary neutron dose for 18 MV dynamic MLC IMRT delivery. , 2005, Medical physics.
[15] D Huyskens,et al. Peripheral neutron and gamma doses in radiotherapy with an 18 MV linear accelerator. , 2004, Radiation protection dosimetry.
[16] K. Turek,et al. Characterisation of neutron fields around high-energy x-ray radiotherapy machines. , 2004, Radiation protection dosimetry.
[17] A. Dell'Acqua,et al. Geant4 - A simulation toolkit , 2003 .
[18] M. Pelliccioni,et al. Overview of Fluence-to-Effective Dose and Fluence-to-Ambient Dose Equivalent Conversion Coefficients for High Energy Radiation Calculated Using the FLUKA Code , 2000 .
[19] K. Kase,et al. Neutron fluence and energy spectra around the Varian Clinac 2100C/2300C medical accelerator. , 1998, Health physics.
[20] K. Kase,et al. Calculations of the Giant-Dipole-Resonance Photoneutrons Using a Coupled EGS4-Morse Code , 1997 .
[21] G. Borasi,et al. Radiation transport in a radiotherapy room. , 1995, Health physics.
[22] M Matzke,et al. Unfolding of pulse height spectra : the HEPRO program system , 1994 .
[23] C. Manfredotti,et al. Evaluation of the Undesired Neutron Dose Equivalent to Critical Organs in Patients Treated by Linear Accelerator Gamma Ray Therapy , 1992 .
[24] W. J. Meredith. Radioactivity: Recommendations of the International Commission on Radiological Units and Measurements , 1963 .